Literature DB >> 31300725

Update of the European consensus on sarcopenia: what has changed in diagnosis and prevalence in peritoneal dialysis?

Maryanne Zilli Canedo da Silva1, Barbara Perez Vogt2, Nayrana Soares do Carmo Reis1, Jacqueline Costa Teixeira Caramori3.   

Abstract

Patients on peritoneal dialysis (PD) may be affected by sarcopenia, which is a progressive and generalized skeletal muscle disorder characterized by muscle mass atrophy with decline of muscle strength and function. The aim was to evaluate differences in the diagnosis and prevalence of sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP). The screening for sarcopenia was performed in PD patients older than 18 years, with evaluation of appendicular skeletal muscle mass index (ASMMI), handgrip strength (HGS) and gait speed (GS). The diagnosis was according to the 2010 and 2019 versions of EWGSOP consensus on sarcopenia. Fifty subjects on PD were included, mean age 55.74 ± 16.22 years old, 52% female. The prevalence of sarcopenia ranged from 4 to 10% according to cut points and references used.

Entities:  

Year:  2019        PMID: 31300725     DOI: 10.1038/s41430-019-0468-z

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  4 in total

Review 1.  Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients.

Authors:  Yuhei Otobe; Connie M Rhee; Matthew Nguyen; Kamyar Kalantar-Zadeh; Joel D Kopple
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-01-01       Impact factor: 2.894

Review 2.  Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis.

Authors:  Xiaoyu Shu; Taiping Lin; Hui Wang; Yanli Zhao; Tingting Jiang; Xuchao Peng; Jirong Yue
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-05       Impact factor: 12.910

3.  Sarcopenia and Liver Cirrhosis-Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019.

Authors:  Julia Traub; Ina Bergheim; Martin Eibisberger; Vanessa Stadlbauer
Journal:  Nutrients       Date:  2020-02-20       Impact factor: 5.717

Review 4.  Sarcopenia in Chronic Kidney Disease: A Scoping Review of Prevalence, Risk Factors, Association with Outcomes, and Treatment.

Authors:  Varvara Chatzipetrou; Marie-Josée Bégin; Mélany Hars; Andrea Trombetti
Journal:  Calcif Tissue Int       Date:  2021-08-12       Impact factor: 4.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.